TNF therapy for spondyloarthropathy: can we marshal the argument?
P T
PT
Dawes
J C
JC
Packham
J C
JC
Mucklow
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D034462:Dissent and Disputes; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D025242:Spondylarthropathies / Q000188:drug therapy*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha